" class="no-js "lang="en-US"> Carlo Montagner - Medtech Alert
Friday, December 01, 2023
Carlo Montagner

Carlo Montagner

About Carlo Montagner

Carlo Montagner is the CEO and founder of Specialised Therapeutics Australia, an international biopharmaceutical company headquartered in Melbourne, Australia.

A highly experienced global pharmaceutical executive and entrepreneur, Carlo founded the company in 2007 to provide cutting edge healthcare products and technologies to patients in Australia, new Zealand and now, throughout South East Asia.

Prior to founding STA, he was the Los Angeles based president of global pharmaceutical company Abraxis Bioscience and is a former global head of oncology for Berlex Schering AG. He also held senior roles with Sanofi Aventis.

Related Story

Global Sarcoma Therapy Now Approved For New Zealand Patients

February 17 2023

Independent biopharmaceutical company, Specialised Therapeutics (ST), is pleased to announce that its portfolio therapy to […]

New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines

July 11 2022

A NEW drug shown to significantly reduce the risk of cancer recurrence or death in […]